IMMUNOCYTOCHEMICAL EXPRESSION OF K-RAS IN SEROUS EFFUSIONS FROM DIFFERENT PRIMARY TUMORS

被引：0
|
作者：
Chatzis, O. [1 ]
Sioutopoulou, D. [1 ]
Mygdakos, N. [1 ]
Fytili, P. [1 ]
Charalampidis, C. [1 ]
Valeri, R. [1 ]
Destouni, C. [1 ]
机构：
[1] Theagenio Canc Hosp, Dept Cytol, Thessaloniki, Greece
来源：
ACTA CYTOLOGICA | 2010年 / 54卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：475 / 475
页数：1
相关论文
共 50 条
  • [1] Immunocytochemical identification of carcinomas of unknown primary in serous effusions
    Pomjanski, N
    Grote, HJ
    Doganay, P
    Schmiemann, V
    Buckstegge, B
    Böcking, A
    DIAGNOSTIC CYTOPATHOLOGY, 2005, 33 (05) : 309 - 315
  • [2] K-RAS mutations in ovarian and extraovarian lesions of serous tumors of borderline malignancy
    Diebold, J
    Seemüller, F
    Löhrs, U
    LABORATORY INVESTIGATION, 2003, 83 (02) : 251 - 258
  • [3] Incidence of P53 and K-ras alterations in ovarian mucinous and serous tumors
    Morita, K
    Ono, Y
    Fukui, H
    Tomita, S
    Ueda, Y
    Terano, A
    Fujimori, T
    PATHOLOGY INTERNATIONAL, 2000, 50 (03) : 219 - 223
  • [4] K-ras mutations in Mullerian inclusion cysts associated with serous borderline tumors of the ovary
    Alvarez, AA
    Moore, WF
    Robboy, SJ
    Bentley, RC
    Gumbs, C
    Futreal, PA
    Berchuck, A
    GYNECOLOGIC ONCOLOGY, 2001, 80 (02) : 201 - 206
  • [5] Immunocytochemical identification of carcinomas of unknown primary (CUP) in serous effusions
    不详
    PATHOLOGY RESEARCH AND PRACTICE, 2005, 201 (03) : 272 - 272
  • [6] Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients
    Schaner, Marci E.
    Davidson, Ben
    Skrede, Martina
    Reich, Reuven
    Florenes, Vivi Ann
    Risberg, Bjorn
    Berner, Aasmund
    Goldberg, Iris
    Givant-Horwitz, Vered
    Trope, Claes G.
    Kristensen, Gunnar B.
    Nesland, Jahn M.
    Borresen-Dale, Anne-Lise
    MOLECULAR CANCER, 2005, 4 (1)
  • [7] Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients
    Marci E Schaner
    Ben Davidson
    Martina Skrede
    Reuven Reich
    Vivi Ann Flørenes
    Björn Risberg
    Aasmund Berner
    Iris Goldberg
    Vered Givant-Horwitz
    Claes G Tropè
    Gunnar B Kristensen
    Jahn M Nesland
    Anne-Lise Børresen-Dale
    Molecular Cancer, 4
  • [8] Second primary or recurrence?: Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors
    Ortiz, BH
    Ailawadi, M
    Colitti, C
    Muto, MG
    Deavers, M
    Silva, EG
    Berkowitz, RS
    Mok, SC
    Gershenson, DM
    CANCER RESEARCH, 2001, 61 (19) : 7264 - 7267
  • [9] Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors
    Khanna, M
    Park, P
    Zirvi, M
    Cao, WG
    Picon, A
    Day, J
    Paty, P
    Barany, F
    ONCOGENE, 1999, 18 (01) : 27 - 38
  • [10] Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors
    Marilyn Khanna
    Pat Park
    Monib Zirvi
    Weiguo Cao
    Antonio Picon
    Joseph Day
    Philip Paty
    Francis Barany
    Oncogene, 1999, 18 : 27 - 38
12345